ruxolitinib
novartis,incyte
['rux,(-crux),(-trux),(-deruxtecan)', '#mpn', 'ruxolitinib', 'rux,(-crux),(-trux)']
congress| #asco23 summarizes an ongoing study of patients with mf who are being treated with ruxolitinib+cxcr4 enriched tregs (ck0804). a combined treatment might improve clinical outcomes for patients with suboptimal response to ruxolitinib #mpn 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm